专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

AU5816173A PHENOXYCARBOXYLIC ACID DERIVATIVES 未知
公开(公告)号：AU5816173A
公开(公告)日：1975-01-23
申请号：AU5816173
申请日：1973-07-17
申请人： NORITAKA HAMMA , EIICHI MURAYAMA , SHUNJI AONO , MASAYOSHI MINAI , YOSHIO SUZUKI
发明人： HAMMA NORITAKA , MURAYAMA EIICHI , AONO SHUNJI , MINAI MASAYOSHI , SUZUKI YOSHIO
IPC分类号： C07C69/712 , C07C51/00 , C07C59/125 , C07C59/68 , C07C59/70 , C07C62/08 , C07C67/00 , C07C69/66 , C07C201/00 , C07C205/20 , A61K27/00 , C07C63/52 , C07C65/20

2. 发明授权

US4695580A Phenylserine derivatives and processes for preparing the same 失效
标题翻译：苯基丝氨酸衍生物及其制备方法
公开(公告)号：US4695580A
公开(公告)日：1987-09-22
申请号：US683430
申请日：1984-12-19
申请人： Naohito Ohashi , Shoji Nagata , Masashi Nakatsuka , Kikuo Ishizumi , Junki Katsube , Shunji Aono , Teruo Sakurama
发明人： Naohito Ohashi , Shoji Nagata , Masashi Nakatsuka , Kikuo Ishizumi , Junki Katsube , Shunji Aono , Teruo Sakurama
IPC分类号： A61K31/195 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/41 , A61P43/00 , C07C67/00 , C07C213/00 , C07C215/30 , C07C215/36 , C07C215/60 , C07C229/36 , C07C231/00 , C07C237/20 , C07C241/00 , C07C251/76 , C07C313/00 , C07C323/25 , C07C323/29 , C07D207/06 , C07D207/08 , C07D207/32 , C07D207/335 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/44 , C07D213/75 , C07D217/06 , C07D257/04 , C07D257/06 , C07D295/12 , C07D295/125 , C07D295/185 , C07D307/52 , C07D317/58 , C07D319/16 , C07F17/02 , C07K5/065 , A61K31/165 , A61K31/215 , C07D295/18
CPC分类号： C07D207/08 , C07C243/00 , C07D207/06 , C07D207/335 , C07D209/08 , C07D209/14 , C07D209/44 , C07D213/75 , C07D217/06 , C07D257/06 , C07D295/125 , C07D295/185 , C07D307/52 , C07D317/58 , C07D319/16 , C07F17/02 , C07K5/06078
摘要： Novel phenylserine derivatives of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, pharmaceutical compositions, and a process for preparing the compounds are disclosed. The phenylserine derivatives and pharmaceutically acceptable acid addition salts are capable of inhibiting the biosynthesis of leucotrienes and/or antagonistic activity against SRS-A and hence are useful for prophylaxis and treatment of various allergic diseases (e.g. bronchial asthma, allergic nasitis, urticaria), ischemic heart diseases, ischemic encephalopathy, inflammation, or the like.
摘要翻译：公开了下式的新型苯基丝氨酸衍生物及其药学上可接受的酸加成盐，药物组合物及其制备方法。苯基丝氨酸衍生物和药学上可接受的酸加成盐能够抑制白细胞三烯的生物合成和/或对SRS-A的拮抗活性，因此可用于预防和治疗各种过敏性疾病（例如支气管哮喘，过敏性鼻炎，荨麻疹），缺血性心脏病，缺血性脑病，炎症等。

3. 发明授权

US5106860A Thiazolidin-4-one derivatives and acid addition salts thereof useful for treating PAF mediated diseases 失效
标题翻译：噻唑烷-4-酮衍生物及其适用于治疗PAF介导性疾病的酸添加物
公开(公告)号：US5106860A
公开(公告)日：1992-04-21
申请号：US624566
申请日：1990-12-10
申请人： Masao Enomoto , Atsuyuki Kojima , Yoshihiro Komuro , Shigeaki Morooka , Shunji Aono , Yuzuru Sanemitsu , Masato Mizutani , You Tanabe
发明人： Masao Enomoto , Atsuyuki Kojima , Yoshihiro Komuro , Shigeaki Morooka , Shunji Aono , Yuzuru Sanemitsu , Masato Mizutani , You Tanabe
IPC分类号： C07D417/04
CPC分类号： C07D417/04
摘要： Thiazolidin-4-one derivative represented by the following general formula (I) and acid addition salts thereof ##STR1## wherein; R.sup.1 and R.sup.2 are the same or different and denote each(i) a residue represented by the general formula--A--R.sup.4 wherein, A denotes a single bond, C.sub.1 -C.sub.8 alkylene, C.sub.2 -C.sub.8 alkenylene, or C.sub.2 -C.sub.8 alkynylene and R.sup.4 denotes hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.2 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 cycloalkyl, or C.sub.1 -C.sub.6 haloalkyl,or(ii) a residue represented by the general formula ##STR2## wherein, B denotes a single bond or C.sub.1 -C.sub.6 alkylene, R.sup.5 denotes hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 cycloalkyl, substituted silyl, or substituted or unsubstituted aryl, n and n' denote each an integer of 2 to 4, m denotes an integer of 1 to 3, and m' denotes an integer of 0 to 2;R.sup.3 denotes hydrogen, C.sub.1 -C.sub.2 alkyl, allyl, 2-propynyl,or(c) the general formula--F--R.sup.9 wherein, F denotes C.sub.2 -C.sub.6 alkylene and R.sup.9 denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula ##STR3## (R.sup.10 denotes hydrogen, C.sub.2 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkanoyl and R.sup.11 denotes hydrogen or C.sub.1 -C.sub.4 alkyl or R.sup.10 in combination with R.sup.11 denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms.Having selective PAF-antagonistic activities, these compounds are very useful as preventive and curative agents for PAF-induced diseases, for example, various kinds of inflammation, allergic diseases, circulatory diseases, and gastro-intestinal diseases.

4. 发明授权

US4992455A Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor 失效
标题翻译：可用于治疗血小板活化因子引起的疾病的噻唑烷-4-酮衍生物
公开(公告)号：US4992455A
公开(公告)日：1991-02-12
申请号：US196058
申请日：1988-05-19
申请人： Masao Enomoto , Atsuyuki Kojima , Yoshihiro Komuro , Shigeaki Morooka , Shunji Aono , Yuzuru Sanemitsu , Masato Mizutani , You Tanabe
发明人： Masao Enomoto , Atsuyuki Kojima , Yoshihiro Komuro , Shigeaki Morooka , Shunji Aono , Yuzuru Sanemitsu , Masato Mizutani , You Tanabe
IPC分类号： C07D417/04
CPC分类号： C07D417/04
摘要： Thiazolidin-4-one derivative represented by the folowing general formula (I) and acid addition salts thereof ##STR1## wherein; R.sup.1 and R.sup.2 are the same or different and denote each(i) a residue represented by the general formula--A--R.sup.4 wherein, A denotes a single bond, C.sub.1 -C.sub.8 alkylene, C.sub.2 -C.sub.8 alkenylene, or C.sub.2 -C.sub.8 alkynylene and R.sup.4 denotes hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.2 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 cycloalkyl, or C.sub.1 -C.sub.6 haloalkyl, or(ii) a residue represented by the general formula{(CH.sub.2).sub.n O}.sub.m {(CH.sub.2).sub.n' O}B--R.sup.5 wherein, B denotes a single bond or C.sub.1 -C.sub.6 alkylene, R.sup.5 denotes hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 cycloalkyl, substituted silyl, or substituted or unsubstituted aryl, n and n' denote each an integer of 2 to 4, m denotes an integer of 1 to 3, and m' denotes an integer of 0 to 2; andR.sup.3 denotes hydrogen, C.sub.1 -C.sub.2 alkyl, allyl, 2-propynyl, or a residue represented by(a) the general formula--CH.sub.2).sub.l R.sup.6 wherein, R.sup.6 denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C.sub.1 -C.sub.4 alkoxy groups, or a residue represented by the general formula --D--R.sup.7 (D denotes oxygen or sulfur and R.sup.7 denotes hydrogen, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkanol) and l denotes an integer of 2 to 4,(b) the general formula--CH.sub.2).sub.k CO--E--R.sup.8 wherein, E denotes oxygen, sulfur, imino, or C.sub.1 -C.sub.4 alkylimino, R.sup.8 denotes hydrogen or C.sub.1 -C.sub.4 alkyl, or --(E--R.sup.8) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or(c) the general formula--F--R.sup.9 wherein, F denotes C.sub.2 -C.sub.6 alkylene and R.sup.9 denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula ##STR2## (R.sup.10 denotes hydrogen, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkyl or R.sup.10 in combination with R.sup.11 denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms), with the proviso that, when R.sup.1 is hydrogen and R.sup.2 is methyl, R.sup.3 denotes hydrogen, C.sub.1 -C.sub.2 alkyl, 2-propynyl, or a residue represented by(a) the general formula--CH.sub.2).sub.l R.sup.6 wherein, R.sup.6 denotes halogen, an aryl group substituted or unsubstituted by one or more hydroxy or C.sub.1 -C.sub.4 alkoxy groups, or a residue represented by the general formula --D--R.sup.7 (D denotes oxygen or sulfur and R.sup.7 denotes hydrogen, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkanoyl) and l denotes an integer of 2 to 4,(b) the general formula--CH.sub.2).sub.k CO--E--R.sup.8 wherein, E denotes oxygen, sulfur, imino, or C.sub.1 -C.sub.4 alkylimino, R.sup.8 denotes hydrogen or C.sub.1 -C.sub.4 alkyl, or --(E--R.sup.8) denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms, and k denotes an integer of 1 to 3, or(c) the general formula--F--R.sup.9 wherein, F denotes C.sub.2 -C.sub.6 alkylene and R.sup.9 denotes a nitrogen-containing heterocyclic aromatic residue or an amino group represented by the general formula ##STR3## (R.sup.10 denotes hydrogen, C.sub.2 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkanoyl and R.sup.11 denotes hydrogen or C.sub.1 -C.sub.4 alkyl or R.sup.10 in combination with R.sup.11 denotes a 5- to 7-membered cyclic amino group which optionally contains other hetero atoms.Having selective PAF-antagonistic activities, these compounds are very useful as preventive and curative agents for PAF-induced diseases, for example, various kinds of inflammation, allergic diseases, circulatory diseases, and gastro-intestinal diseases.

5. 发明授权

US4228167A Diuretic and vasodilating tricyclic quinazolines 失效
标题翻译：利尿和血管舒张三环喹唑啉
公开(公告)号：US4228167A
公开(公告)日：1980-10-14
申请号：US939869
申请日：1978-09-05
申请人： Michihiro Yamamoto , Masao Koshiba , Shunji Aono
发明人： Michihiro Yamamoto , Masao Koshiba , Shunji Aono
IPC分类号： A61K31/505 , A61P7/10 , C07D487/04 , C07D487/14
CPC分类号： C07D487/04 , Y10S514/869
摘要： Novel imidazo[2,1-b]quinazolines and pyrimido-[2,1-b]quinozolines represented by the formula, ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and A are as defined in the specification were prepared. They have prominent pharmacological properties such as diuretic and vasodilating activity.
摘要翻译：由式表示的新型咪唑并[2,1-b]喹唑啉和嘧啶并[2,1-b]喹唑啉，其中R1，R2，R3，R4，R5和A如说明书中所定义。它们具有突出的药理学性质，如利尿和血管扩张活性。

6. 发明授权

US4031134A Phenoxy carboxylic acid derivative 失效
标题翻译：苯氧基羧酸衍生物
公开(公告)号：US4031134A
公开(公告)日：1977-06-21
申请号：US292110
申请日：1972-09-25
申请人： Yasushi Nakamura , Kunio Agatsuma , Yoshihiro Tanaka , Shunji Aono
发明人： Yasushi Nakamura , Kunio Agatsuma , Yoshihiro Tanaka , Shunji Aono
IPC分类号： C07C51/367 , C07C51/41 , C07C59/68 , C07C59/72 , C07C65/14 , C07C69/76
CPC分类号： C07C59/72 , C07C51/367 , C07C51/412 , C07C59/68
摘要： Novel anti-atherosolerosis agents having the formula, ##STR1## wherein typical examples of R.sup.1 and R.sup.2 are hydrogen, C.sub.1 -C.sub.8 alkyl, phenyl, benzyl and phenethyl, or R.sup.1 and R.sup.2 may form cycloalkylidene together with a carbon atom bonded therewith; R.sup.3 and R.sup.4 each is hydrogen or C.sub.1 -C.sub.4 alkyl; Y is hydroxyl, C.sub.1 -C.sub.4 alkoxy, phenoxy or an amine residue; A is hydrogen or a group of the formula, ##STR2## wherein R.sup.3, and R.sup.4 and Y have the same meanings as defined above; and D and E each is hydrogen or halogen.These compounds are produced, for example, by reacting a bisphenolic compound of the formula, ##STR3## with chloroform and a ketone compound of the formula,R.sup.3 -- CO -- R.sup.4in the presence of an alkali. Alternatively, they are produced by reacting the bisphenolic compound with .alpha.-halogeno- or .alpha.-hydroxycarboxylic acid derivative of the formula, ##STR4## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, D, E and Y have the same meanings as defined above; and X is halogen or hydroxyl.
摘要翻译：具有下式的新型抗动脉粥样硬化剂：其中R1和R2的典型实例是氢，C1-C8烷基，苯基，苄基和苯乙基，或R1和R2可以与其键合的碳原子一起形成亚环烷基; R3和R4各自为氢或C1-C4烷基; Y是羟基，C 1 -C 4烷氧基，苯氧基或胺残基; A是氢或下式的基团，其中R3，R4和Y具有与上述相同的含义; D和E各自为氢或卤素。

7. 发明授权

US4461774A Antifungal imidazolylcarboxylic acids and their derivatives 失效
标题翻译：抗真菌咪唑基羧酸及其衍生物
公开(公告)号：US4461774A
公开(公告)日：1984-07-24
申请号：US427558
申请日：1982-09-29
申请人： Ikutaro Saji , Hiroshi Yamazaki , Shunji Aono , Katsuaki Ichise , Takao Okuda
发明人： Ikutaro Saji , Hiroshi Yamazaki , Shunji Aono , Katsuaki Ichise , Takao Okuda
IPC分类号： A01N43/50 , A61K31/415 , A61P31/04 , A61P31/10 , C07D233/60 , C07D521/00
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08
摘要： An imidazolylcarboxylic acid compound of the formula: ##STR1## wherein Ph is a phenyl group or a phenyl group substituted with one or two halogen atoms, R is a hydrogen atom or a C.sub.1 -C.sub.8 alkyl group and n is an integer of 1 to 8, which is useful as an antifungal agent.
摘要翻译：下式的咪唑基羧酸化合物：其中Ph是苯基或被一个或两个卤素原子取代的苯基，R是氢原子或C1-C8烷基，n是1至8的整数，其可用作抗真菌剂。

8. 发明授权

US4092324A Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane).alpha.-methyl substituted 失效
标题翻译： 4-（1,1-双 - （苯氧基 - 丙酸） - 环己烷）（60-甲基取代的）的二杂环酯
公开(公告)号：US4092324A
公开(公告)日：1978-05-30
申请号：US716666
申请日：1976-08-23
申请人： Yoshio Suzuki , Masayoshi Minai , Noritaka Hamma , Eiichi Murayama , Shunji Aono
发明人： Yoshio Suzuki , Masayoshi Minai , Noritaka Hamma , Eiichi Murayama , Shunji Aono
IPC分类号： C07D211/46 , C07D213/30 , C07D213/75 , C07D213/55
CPC分类号： C07D213/30 , C07D211/46 , C07D213/75
摘要： Bisphenoxy carboxylic acid derivatives useful as an antiarteriosclerosis agent with good absorbability and low toxicity, which are novel compounds represented by the general formula, ##STR1## wherein R.sub.1 and R.sub.2 represent hydrogen atoms or lower alkyl groups and A preresents ##STR2## (wherein in case R.sub.3 is a hydrogen atom, R.sub.4 represents an amino-lower-alkyl group, an N-lower-alkylaminoalkyl group, a heterocyclic group, or a heterocyclic group-substituted alkyl group; or R.sub.3 and R.sub.4 may join through an intermediary hetero atom to form a heterocyclic group and if said hetero atom is a nitrogen atom, this nitrogen atom can bear a lower alkyl group as a substituent) or ##STR3## (wherein R.sub.5 represents a hydrogen atom, a hydroxyalkyl group or a derivative thereof, and R.sub.6 represents a hydroxyalkyl group or a heterocyclic group; or R.sub.5 and R.sub.6 may join to form a cyclic group, or may join through another intermediary hetero atom to form a heterocyclic group and if said hetero atom is a nitrogen atom, this nitrogen atom can bear a lower alkyl group as a substituent).
摘要翻译：作为具有良好吸收性和低毒性的抗动脉硬化剂的双苯氧基羧酸衍生物，它们是由通式表示的新化合物，其中R 1和R 2表示氢原子或低级烷基，并且A表示（其中，在R 3为氢原子的情况下，R 4表示氨基 - 低级烷基，N-低级烷基氨基烷基，杂环基或杂环基取代的烷基;或者，R 3和R 4可以通过中间杂原子原子形成杂环基，如果所述杂原子是氮原子，则该氮原子可以具有作为取代基的低级烷基）或者其中R5表示氢原子，羟烷基或其衍生物，和 R6表示羟基烷基或杂环基;或者R5和R6可以连接形成环状基团，或者可以通过另一个中间杂原子连接形成杂环基，如果所述杂原子是氮原子，该氮原子可以具有低级烷基作为取代基）。

9. 发明授权

US3970694A Cycloalkyl phenoxy carboxylic acid derivatives 失效
标题翻译：环烷基苯氧基羧酸衍生物
公开(公告)号：US3970694A
公开(公告)日：1976-07-20
申请号：US484063
申请日：1974-06-28
申请人： Masayoshi Minai , Yoshio Suzuki , Noritaka Hamma , Eiichi Murayama , Shunji Aono
发明人： Masayoshi Minai , Yoshio Suzuki , Noritaka Hamma , Eiichi Murayama , Shunji Aono
IPC分类号： A61K31/19 , A61K31/215 , A61K31/22 , A61P3/06 , A61P9/10 , C07C51/00 , C07C59/125 , C07C59/68 , C07C59/70 , C07C67/00 , C07C69/712 , C07C63/33
CPC分类号： C07C59/70 , C07C59/68 , C07C69/712 , Y10S514/824
摘要： Novel compounds having the formula, ##SPC1##Wherein R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen or a C.sub.1 -C.sub.4 alkyl; n is an integer of 4-6; and Y is hydrogen or a group of the formula ##EQU1## wherein R.sub.1, R.sub.2 and R.sub.3 are as defined above. These compounds are produced, for example, by reacting a bisphenolic compound of the formula, ##SPC2##With chloroform and a ketone compound of the formula,R.sub.1 -- CO -- R.sub.2in the presence of an alkali. Alternatively, they are produced by reacting the bisphenolic compound with .alpha.-halogeno- or .alpha.-hydroxycarboxylic acid derivative of the formula, ##EQU2## wherein R.sub.1, R.sub.2, and R.sub.3 are as defined above, and X is a halogen or hydroxyl. The novel compounds are anti-atherosclerosis agents useful for lowering elevated levels of cholesterol or lipids.
摘要翻译：具有式WHEREIN R1，R2和R3的新型化合物各自独立地为氢或C1-C4烷基; n为4-6的整数; 并且Y是氢或式R1R2 ANGLE -C-COOR3的基团，其中R1，R2和R3如上定义。

10. 发明授权

US06586022B2 Therapeutic agent for treating ulcerative colitis 失效
公开(公告)号：US06586022B2
公开(公告)日：2003-07-01
申请号：US09924539
申请日：2001-08-09
申请人： Mitsuhiro Kawada , Ken-ichi Hattori , Shunji Aono
发明人： Mitsuhiro Kawada , Ken-ichi Hattori , Shunji Aono
IPC分类号： A61K3578
CPC分类号： A61K36/65 , A61K2300/00
摘要： An ulcerative colitis treating therapeutic agent which is very effective in repairing damaged tissues of ulcerative colitis and yet has no need of fear of side effects as those of steroids is provided. It is an therapeutic agent for treating ulcerative colitis which has peony root, especially, dry powders of peony root, or a Chinese medicine formulation containing peony root as an active ingredient. It is also an therapeutic agent for treating ulcerative colitis which has, as an active ingredient, an infused dry extract of peony root, an infused dry extract of a Chinese medicine formulation containing peony root, or especially an infused dry extract of Jia-Wei-Xiao-Yao-San, Dang-Gui-Shao-Yao-San, Shao-Yao-Gan-Cao-Tang, or Gui-Zhi-Fu-Ling-Wan.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式